Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 0.3950
0.00 (0.00%)
Jul 6, 2026, 11:35 AM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 36.46 million as of July 6, 2026. Its market cap has decreased by -51.95% in one year.
Market Cap
36.46M
Enterprise Value
30.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has decreased from 65.63M to 36.46M, a decrease of -44.45%. That is a compound annual growth rate of -6.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 36.46M | -52.49% |
| Dec 31, 2025 | 76.75M | -40.53% |
| Dec 31, 2024 | 129.06M | 341.25% |
| Dec 29, 2023 | 29.25M | -34.38% |
| Dec 30, 2022 | 44.57M | -60.68% |
| Dec 31, 2021 | 113.36M | -62.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 51.18M |
| MedMira | 49.12M |
| Sernova Biotherapeutics | 49.09M |
| Microbix Biosystems | 41.33M |
| BriaCell Therapeutics | 39.58M |
| Defence Therapeutics | 32.97M |
| Resverlogix | 30.95M |
| Quantum BioPharma | 30.39M |